| Study 1 — Lithuania (Dec 2024) |
outcome (DV — FIMI) |
FIMI |
15 |
681 |
0.93 |
0.93 |
0.47 |
0.48 |
2.72 |
1.42 |
2.53 |
1.20 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
outcome (DV — FIMI) |
FIMI_SHORT |
4 |
681 |
0.81 |
0.82 |
0.53 |
0.54 |
2.54 |
1.51 |
2.25 |
1.25 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
ANXK |
5 |
681 |
0.92 |
0.92 |
0.70 |
0.70 |
3.74 |
1.84 |
3.80 |
1.40 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
ANXR |
5 |
681 |
0.92 |
0.93 |
0.71 |
0.71 |
3.09 |
1.97 |
2.60 |
1.60 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
FEAR |
2 |
681 |
0.79 |
0.79 |
0.66 |
0.66 |
4.03 |
2.05 |
4.00 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
GAY |
3 |
681 |
0.90 |
0.91 |
0.76 |
0.78 |
4.70 |
2.07 |
5.00 |
2.00 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
LEFT |
2 |
681 |
0.79 |
0.80 |
0.66 |
0.66 |
3.69 |
1.87 |
3.50 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
LONE |
4 |
681 |
0.92 |
0.92 |
0.73 |
0.73 |
3.79 |
1.88 |
3.75 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
MIGR |
2 |
681 |
0.82 |
0.82 |
0.70 |
0.70 |
4.85 |
1.71 |
5.00 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
RULE |
2 |
681 |
0.78 |
0.78 |
0.65 |
0.65 |
3.04 |
1.82 |
2.50 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
SAFE |
3 |
681 |
0.83 |
0.83 |
0.63 |
0.63 |
3.30 |
1.80 |
3.00 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
SUPK |
10 |
681 |
0.95 |
0.95 |
0.63 |
0.63 |
3.72 |
1.54 |
3.90 |
1.10 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
SUPR |
12 |
681 |
0.96 |
0.96 |
0.69 |
0.66 |
2.74 |
1.70 |
2.25 |
1.17 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
THREAT |
2 |
681 |
0.80 |
0.80 |
0.67 |
0.67 |
3.91 |
2.08 |
4.00 |
2.00 |
1.00 |
7.00 |
0.00% |
| Study 1 — Lithuania (Dec 2024) |
DisInformeter scale predictor |
USE |
6 |
681 |
0.92 |
0.92 |
0.66 |
0.66 |
3.79 |
1.77 |
3.67 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
outcome (DV — FIMI) |
FIMI |
8 |
582 |
0.78 |
0.79 |
0.31 |
0.32 |
5.22 |
1.11 |
5.25 |
0.75 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
outcome (DV — FIMI) |
FIMI_SHORT |
4 |
582 |
0.69 |
0.69 |
0.36 |
0.36 |
5.20 |
1.22 |
5.25 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
ABAND |
3 |
582 |
0.80 |
0.80 |
0.57 |
0.56 |
3.80 |
1.67 |
4.00 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
ABANF |
4 |
582 |
0.91 |
0.91 |
0.71 |
0.71 |
3.84 |
1.67 |
4.00 |
1.25 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
ABANH |
5 |
582 |
0.93 |
0.93 |
0.71 |
0.72 |
3.89 |
1.84 |
4.00 |
1.60 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
ABANM |
4 |
582 |
0.95 |
0.95 |
0.82 |
0.83 |
3.57 |
1.94 |
3.75 |
1.62 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
EXPL |
4 |
582 |
0.90 |
0.90 |
0.70 |
0.70 |
3.85 |
1.70 |
4.00 |
1.25 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
GAY |
3 |
582 |
0.94 |
0.94 |
0.84 |
0.84 |
4.35 |
2.14 |
4.33 |
2.00 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
MIGR |
3 |
582 |
0.90 |
0.90 |
0.75 |
0.76 |
5.11 |
1.61 |
5.33 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
PRAG |
2 |
582 |
0.75 |
0.75 |
0.60 |
0.60 |
4.33 |
1.92 |
4.50 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
PRAGR |
4 |
582 |
0.90 |
0.90 |
0.69 |
0.69 |
3.02 |
1.86 |
2.62 |
1.62 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
SUPF |
3 |
582 |
0.94 |
0.94 |
0.84 |
0.84 |
1.92 |
1.53 |
1.00 |
0.00 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
SUPR |
6 |
582 |
0.93 |
0.93 |
0.70 |
0.70 |
2.34 |
1.56 |
1.75 |
0.75 |
1.00 |
7.00 |
0.00% |
| Study 2 — Lithuania (Mar 2025) |
DisInformeter scale predictor |
THREAT |
3 |
582 |
0.73 |
0.74 |
0.48 |
0.47 |
4.05 |
1.63 |
4.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
outcome (DV — FIMI) |
FIMI |
8 |
782 |
0.55 |
0.56 |
0.13 |
0.14 |
4.64 |
0.89 |
4.62 |
0.62 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
outcome (DV — FIMI) |
FIMI_SHORT |
4 |
782 |
0.40 |
0.41 |
0.14 |
0.16 |
4.83 |
1.08 |
4.75 |
0.75 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
ABAND |
3 |
782 |
0.82 |
0.82 |
0.61 |
0.60 |
3.72 |
1.73 |
3.67 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
ABANF |
4 |
782 |
0.91 |
0.91 |
0.71 |
0.72 |
3.29 |
1.63 |
3.25 |
1.25 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
ABANH |
5 |
782 |
0.94 |
0.94 |
0.76 |
0.77 |
3.82 |
1.92 |
3.80 |
1.60 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
ABANM |
4 |
782 |
0.95 |
0.95 |
0.83 |
0.83 |
3.20 |
1.96 |
3.00 |
1.75 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
EXPL |
4 |
782 |
0.87 |
0.88 |
0.63 |
0.63 |
3.66 |
1.62 |
3.75 |
1.25 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
GAY |
3 |
782 |
0.96 |
0.96 |
0.88 |
0.88 |
2.85 |
1.96 |
2.33 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
MIGR |
3 |
782 |
0.95 |
0.95 |
0.85 |
0.85 |
4.25 |
2.02 |
4.33 |
1.67 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
PRAG |
2 |
782 |
0.84 |
0.84 |
0.72 |
0.72 |
4.04 |
2.02 |
4.00 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
PRAGR |
4 |
782 |
0.91 |
0.91 |
0.72 |
0.72 |
3.48 |
1.91 |
3.50 |
1.75 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
SUPF |
3 |
782 |
0.88 |
0.90 |
0.73 |
0.76 |
2.36 |
1.63 |
1.67 |
0.67 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
SUPR |
6 |
782 |
0.92 |
0.92 |
0.65 |
0.63 |
2.93 |
1.58 |
2.67 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 3 — Germany (May 2025) |
DisInformeter scale predictor |
THREAT |
3 |
782 |
0.75 |
0.76 |
0.51 |
0.52 |
3.35 |
1.67 |
3.33 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
outcome (DV — FIMI) |
FIMI |
8 |
8040 |
0.69 |
0.69 |
0.22 |
0.23 |
4.86 |
0.99 |
4.88 |
0.62 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
outcome (DV — FIMI) |
FIMI_SHORT |
4 |
8040 |
0.53 |
0.53 |
0.22 |
0.23 |
4.86 |
1.11 |
4.75 |
0.75 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
CLICK_REASONS |
6 |
8040 |
0.86 |
0.86 |
0.50 |
0.51 |
3.99 |
1.39 |
4.00 |
0.83 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
DEM_IMPORT |
1 |
8040 |
NA |
NA |
NA |
NA |
9.25 |
2.24 |
10.00 |
1.00 |
1.00 |
11.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
EU_SUPPORT |
1 |
8040 |
NA |
NA |
NA |
NA |
6.84 |
3.28 |
7.00 |
2.00 |
1.00 |
12.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
INST_TRUST |
8 |
8040 |
0.90 |
0.90 |
0.53 |
0.53 |
5.51 |
2.19 |
5.62 |
1.50 |
1.00 |
11.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
LIFE_SAT |
1 |
8040 |
NA |
NA |
NA |
NA |
6.66 |
2.48 |
7.00 |
2.00 |
1.00 |
11.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
LR_SCALE |
1 |
8040 |
NA |
NA |
NA |
NA |
6.33 |
2.36 |
6.00 |
1.00 |
1.00 |
11.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MEDIA_FREQ |
5 |
8040 |
0.61 |
0.62 |
0.23 |
0.26 |
4.16 |
1.26 |
4.20 |
0.80 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_ACTION |
6 |
8040 |
NA |
NA |
NA |
NA |
1.72 |
0.95 |
1.00 |
0.00 |
0.00 |
6.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_CONF |
1 |
8040 |
NA |
NA |
NA |
NA |
5.01 |
1.49 |
5.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_FOREIGN |
9 |
8040 |
0.89 |
0.89 |
0.47 |
0.47 |
4.45 |
1.11 |
4.44 |
0.67 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_FREE |
1 |
8040 |
NA |
NA |
NA |
NA |
4.36 |
1.76 |
4.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_IMPACT |
6 |
8040 |
0.90 |
0.90 |
0.59 |
0.60 |
4.72 |
1.32 |
4.67 |
0.83 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_POL |
1 |
8040 |
NA |
NA |
NA |
NA |
5.20 |
1.43 |
5.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_REGUL |
2 |
8040 |
0.65 |
0.65 |
0.48 |
0.48 |
5.25 |
1.27 |
5.50 |
0.50 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_RESP |
9 |
8040 |
0.94 |
0.94 |
0.63 |
0.64 |
5.40 |
1.29 |
5.56 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
MISINFO_SRC |
9 |
8040 |
0.89 |
0.89 |
0.48 |
0.49 |
4.74 |
1.10 |
4.78 |
0.78 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
POL_EFF_EXT |
1 |
8040 |
NA |
NA |
NA |
NA |
2.05 |
0.91 |
2.00 |
1.00 |
1.00 |
4.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
POL_EFF_INT |
1 |
8040 |
NA |
NA |
NA |
NA |
2.34 |
1.13 |
2.00 |
1.00 |
1.00 |
5.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
POL_INTEREST |
1 |
8040 |
NA |
NA |
NA |
NA |
2.34 |
0.87 |
2.00 |
1.00 |
1.00 |
4.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
POL_PARTIC |
8 |
8040 |
NA |
NA |
NA |
NA |
1.09 |
1.33 |
1.00 |
1.00 |
0.00 |
8.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
RELIGIOSITY |
1 |
8040 |
NA |
NA |
NA |
NA |
5.23 |
3.12 |
6.00 |
3.00 |
1.00 |
11.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
COND experimental outcome |
SOC_TRUST |
3 |
8040 |
0.80 |
0.81 |
0.58 |
0.58 |
6.44 |
2.30 |
6.67 |
1.67 |
2.00 |
12.33 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
ABAND |
3 |
8040 |
0.76 |
0.76 |
0.51 |
0.51 |
4.43 |
1.55 |
4.33 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
ABAND_LONG |
6 |
8040 |
0.87 |
0.87 |
0.52 |
0.53 |
4.37 |
1.46 |
4.33 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
GEN |
5 |
8040 |
0.63 |
0.65 |
0.25 |
0.31 |
4.05 |
1.16 |
4.00 |
0.80 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
PRAG |
1 |
8040 |
NA |
NA |
NA |
NA |
4.68 |
1.91 |
5.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
PRAG_LONG |
3 |
8040 |
0.71 |
0.76 |
0.46 |
0.54 |
4.95 |
1.42 |
5.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
SUPCH |
3 |
8040 |
0.94 |
0.94 |
0.83 |
0.83 |
3.04 |
1.78 |
3.00 |
1.67 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
SUPR |
3 |
8040 |
0.95 |
0.95 |
0.86 |
0.86 |
2.70 |
1.87 |
2.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
THREAT |
2 |
8040 |
0.53 |
0.54 |
0.37 |
0.39 |
4.40 |
1.65 |
4.50 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 4 — Cross-national experiment (2025) |
DisInformeter scale predictor |
THREAT_LONG |
7 |
8040 |
0.86 |
0.86 |
0.46 |
0.47 |
4.64 |
1.41 |
4.71 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
ABAND |
8 |
248 |
0.87 |
0.87 |
0.45 |
0.36 |
3.11 |
1.19 |
3.00 |
0.75 |
1.00 |
6.62 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
ABAN_STATE |
5 |
248 |
0.92 |
0.92 |
0.71 |
0.71 |
2.66 |
1.43 |
2.20 |
0.80 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
CEN |
6 |
248 |
0.94 |
0.94 |
0.72 |
0.72 |
2.41 |
1.50 |
1.83 |
0.83 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
CET |
8 |
248 |
0.79 |
0.79 |
0.31 |
0.44 |
3.57 |
0.98 |
3.62 |
0.75 |
1.00 |
6.25 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
EXPL |
5 |
248 |
0.78 |
0.78 |
0.41 |
0.44 |
3.02 |
1.15 |
3.00 |
0.80 |
1.00 |
6.60 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
FEAR |
6 |
248 |
0.83 |
0.84 |
0.46 |
0.53 |
4.50 |
1.34 |
4.50 |
0.83 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
GAY |
6 |
248 |
0.91 |
0.92 |
0.66 |
0.82 |
2.73 |
1.61 |
2.17 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
GEN |
8 |
248 |
0.57 |
0.66 |
0.16 |
0.28 |
3.16 |
0.78 |
3.12 |
0.50 |
1.00 |
6.50 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
MIGR |
7 |
248 |
0.90 |
0.90 |
0.55 |
0.77 |
3.05 |
1.30 |
2.86 |
0.86 |
1.00 |
6.57 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
PRAGCH |
6 |
248 |
0.87 |
0.87 |
0.53 |
0.53 |
3.02 |
1.46 |
2.92 |
1.08 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
PRAGR |
6 |
248 |
0.86 |
0.87 |
0.52 |
0.58 |
2.24 |
1.32 |
2.00 |
0.83 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
SUPCH |
11 |
248 |
0.91 |
0.91 |
0.48 |
0.55 |
3.18 |
1.22 |
3.09 |
0.82 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
SUPR |
12 |
248 |
0.92 |
0.93 |
0.51 |
0.55 |
1.77 |
0.97 |
1.50 |
0.50 |
1.00 |
6.17 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
SUP_GEN |
8 |
248 |
0.92 |
0.93 |
0.64 |
0.64 |
1.78 |
1.14 |
1.25 |
0.25 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
THREAT |
12 |
248 |
0.85 |
0.85 |
0.31 |
0.32 |
3.49 |
1.15 |
3.42 |
0.92 |
1.17 |
6.83 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
THREAT_FT |
3 |
248 |
0.71 |
0.75 |
0.44 |
0.53 |
3.44 |
1.44 |
3.33 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
THREAT_GAY |
3 |
248 |
0.97 |
0.97 |
0.91 |
0.91 |
2.51 |
1.88 |
1.67 |
0.67 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
THREAT_MIGR |
2 |
248 |
0.90 |
0.90 |
0.82 |
0.82 |
3.70 |
1.85 |
3.50 |
1.50 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
DisInformeter scale predictor |
UNP |
4 |
248 |
0.87 |
0.87 |
0.62 |
0.64 |
2.85 |
1.32 |
2.50 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
CMQ |
5 |
248 |
0.84 |
0.84 |
0.51 |
0.52 |
6.69 |
2.22 |
6.80 |
1.60 |
1.00 |
11.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
FEEL_CH |
1 |
247 |
NA |
NA |
NA |
NA |
21.08 |
22.77 |
15.00 |
15.00 |
0.00 |
100.00 |
0.40% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
FEEL_EU |
1 |
248 |
NA |
NA |
NA |
NA |
81.37 |
17.64 |
85.00 |
10.00 |
0.00 |
100.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
FEEL_NATO |
1 |
248 |
NA |
NA |
NA |
NA |
73.88 |
22.66 |
80.00 |
12.00 |
0.00 |
100.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
FEEL_RU |
1 |
247 |
NA |
NA |
NA |
NA |
5.22 |
15.09 |
0.00 |
0.00 |
0.00 |
100.00 |
0.40% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
ITT_IMI |
6 |
248 |
0.94 |
0.94 |
0.72 |
0.72 |
2.81 |
1.51 |
2.50 |
1.17 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
ITT_IMI_REAL |
3 |
248 |
0.93 |
0.93 |
0.81 |
0.81 |
2.97 |
1.64 |
2.67 |
1.33 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
ITT_IMI_SYM |
3 |
248 |
0.96 |
0.97 |
0.90 |
0.90 |
2.66 |
1.65 |
2.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
ITT_LGBT |
8 |
248 |
0.93 |
0.93 |
0.62 |
0.63 |
2.23 |
1.39 |
1.75 |
0.75 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
ITT_LGBT_REAL |
4 |
248 |
0.82 |
0.84 |
0.56 |
0.57 |
1.90 |
1.24 |
1.25 |
0.25 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
ITT_LGBT_SYM |
4 |
248 |
0.94 |
0.95 |
0.82 |
0.82 |
2.56 |
1.73 |
2.00 |
1.00 |
1.00 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
PANAS_NA |
5 |
247 |
0.81 |
0.82 |
0.46 |
0.48 |
3.42 |
1.08 |
3.40 |
0.80 |
1.20 |
6.60 |
0.40% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
PANAS_PA |
5 |
248 |
0.73 |
0.74 |
0.36 |
0.38 |
4.84 |
0.93 |
5.00 |
0.60 |
1.80 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
POP |
9 |
248 |
0.40 |
0.46 |
0.08 |
0.12 |
4.66 |
0.62 |
4.67 |
0.44 |
3.00 |
6.22 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
POP_ELITE |
3 |
248 |
0.27 |
0.48 |
0.11 |
0.37 |
4.53 |
0.95 |
4.67 |
0.67 |
1.67 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
POP_MANI |
3 |
247 |
0.18 |
0.45 |
0.07 |
0.36 |
3.84 |
1.03 |
4.00 |
0.67 |
1.00 |
6.67 |
0.40% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
POP_PEOPLE |
3 |
248 |
0.36 |
0.49 |
0.19 |
0.30 |
5.60 |
0.90 |
5.67 |
0.67 |
2.67 |
7.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
RWA |
6 |
248 |
0.56 |
0.63 |
0.15 |
0.27 |
3.95 |
1.28 |
3.83 |
1.00 |
1.00 |
7.67 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
TRUST_EU |
1 |
248 |
NA |
NA |
NA |
NA |
6.16 |
2.10 |
7.00 |
1.00 |
1.00 |
10.00 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
TRUST_LOCAL |
5 |
248 |
0.86 |
0.86 |
0.55 |
0.55 |
4.98 |
1.63 |
5.00 |
1.20 |
1.00 |
9.20 |
0.00% |
| Study 5 — Lithuania validation (Mar-Apr 2026) |
validation battery |
TRUST_UN |
1 |
248 |
NA |
NA |
NA |
NA |
5.67 |
2.62 |
6.00 |
2.00 |
1.00 |
10.00 |
0.00% |